Trial Profile
Assessment and Prevention of Menstrual Migraine: Phase 1-prospective Survey of Self-identified Menstrual Migraine. Phase 2-prevention of Menstrual Migraine With Relpax.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2011
Price :
$35
*
At a glance
- Drugs Eletriptan (Primary)
- Indications Menstrual migraine
- Focus Therapeutic Use
- 11 Nov 2008 Status changed from recruiting to completed according to ClinicalTrials.gov.
- 20 Sep 2006 New trial record.